HM Payson & Co’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $827K | Buy |
3,744
+1,761
| +89% | +$487K | 0.01% | 250 |
|
|
2026
Q1 | $586K | Sell |
1,983
-725
| -27% | -$215K | 0.01% | 277 |
|
|
2025
Q4 | $740K | Buy |
2,708
+546
| +25% | +$148K | 0.01% | 251 |
|
|
2025
Q3 | $584K | Buy |
2,162
+1,122
| +108% | +$305K | 0.01% | 274 |
|
|
2025
Q2 | $287K | Sell |
1,040
-10
| -1% | -$2.72K | ﹤0.01% | 359 |
|
|
2025
Q1 | $279K | Buy |
1,050
+149
| +17% | +$36.8K | ﹤0.01% | 362 |
|
|
2024
Q4 | $209K | Sell |
901
-61
| -6% | -$14K | ﹤0.01% | 414 |
|
|
2024
Q3 | $212K | Buy |
962
+242
| +34% | +$50.1K | ﹤0.01% | 405 |
|
|
2024
Q2 | $142K | Sell |
720
-205
| -22% | -$42.4K | ﹤0.01% | 464 |
|
|
2024
Q1 | $199K | Buy |
925
+2
| +0.2% | +$420 | ﹤0.01% | 405 |
|
|
2023
Q4 | $194K | Buy |
923
+15
| +2% | +$3.2K | ﹤0.01% | 391 |
|
|
2023
Q3 | $182K | Sell |
908
-100
| -10% | -$19.9K | ﹤0.01% | 388 |
|
|
2023
Q2 | $187K | Sell |
1,008
-349
| -26% | -$64.5K | ﹤0.01% | 380 |
|
|
2023
Q1 | $260K | Buy |
1,357
+200
| +17% | +$36.2K | 0.01% | 330 |
|
|
2022
Q4 | $195K | Sell |
1,157
-300
| -21% | -$52.1K | ﹤0.01% | 373 |
|
|
2022
Q3 | $258K | Buy |
1,457
+801
| +122% | +$158K | 0.01% | 330 |
|
|
2022
Q2 | $134K | Buy |
656
+400
| +156% | +$84.8K | ﹤0.01% | 429 |
|
|
2022
Q1 | $61K | Sell |
256
-88
| -26% | -$20.7K | ﹤0.01% | 568 |
|
|
2021
Q4 | $79K | Sell |
344
-62
| -15% | -$13.6K | ﹤0.01% | 532 |
|
|
2021
Q3 | $79K | Hold |
406
| – | – | ﹤0.01% | 521 |
|
|
2021
Q2 | $86K | Hold |
406
| – | – | ﹤0.01% | 501 |
|
|
2021
Q1 | $83K | Buy |
406
+74
| +22% | +$14.6K | ﹤0.01% | 514 |
|
|
2020
Q4 | $60K | Sell |
332
-200
| -38% | -$34K | ﹤0.01% | 566 |
|
|
2020
Q3 | $89K | Sell |
532
-25
| -4% | -$4.21K | ﹤0.01% | 468 |
|
|
2020
Q2 | $91K | Buy |
557
+100
| +22% | +$17.9K | ﹤0.01% | 443 |
|
|
2020
Q1 | $79K | Sell |
457
-370
| -45% | -$73.6K | ﹤0.01% | 429 |
|
|
2019
Q4 | $166K | Buy |
827
+270
| +48% | +$55.4K | 0.01% | 414 |
|
|
2019
Q3 | $118K | Hold |
557
| – | – | ﹤0.01% | 460 |
|
|
2019
Q2 | $108K | Buy |
+557
| New | +$103K | ﹤0.01% | 480 |
|
|
2016
Q1 | – | Sell |
-27,488
| Closed | -$2.49M | – | 339 |
|
|
2015
Q4 | $2.49M | Buy |
27,488
+167
| +0.6% | +$15.7K | 0.13% | 127 |
|
|
2015
Q3 | $2.53M | Hold |
27,321
| – | – | 0.14% | 121 |
|
|
2015
Q2 | $2.54M | Sell |
27,321
-7
| -0% | -$653 | 0.13% | 131 |
|
|
2015
Q1 | $2.59M | Sell |
27,328
-984
| -3% | -$91.2K | 0.13% | 121 |
|
|
2014
Q4 | $2.51M | Buy |
28,312
+11,070
| +64% | +$938K | 0.12% | 124 |
|
|
2014
Q3 | $1.38M | Buy |
+17,242
| New | +$1.3M | 0.07% | 153 |
|
Other funds holding CME
HM Payson & Co's CME Position: Q2 2026 in Review
HM Payson & Co increased its CME Group (CME) stake by 89% in Q2 2026, buying an estimated $487K and bringing the position to 3,744 shares worth $827K. The position accounts for 0.01% of the portfolio, ranked #250.
HM Payson & Co first reported a position in CME in Q3 2014 and has held it in 35 quarters since. The position peaked at $2.59M in Q1 2015. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- HM Payson & Co held 3,744 shares of CME Group worth $827K as of Q2 2026.
- HM Payson & Co bought 1,761 CME Group shares in Q2 2026, an estimated $487K.
- CME Group made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #250 holding.
- HM Payson & Co first reported a position in CME Group in Q3 2014 and has held it in 35 quarters since.
- HM Payson & Co's CME Group position peaked at $2.59M in Q1 2015.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.